4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...

4/19/2025Haleon Achieves Full Ownership of Tianjin SmithKline JV

4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...

4/19/2025China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...

4/19/2025HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials

4/18/2025WuXi Biologics Completes 15,000L PPQ at Hangzhou Site

4/18/2025VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...

4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...

4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount

4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger

4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal

4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...

4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...

4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...

4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing

4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...

4/17/2025DualityBio Raises $211M in Hong Kong IPO

4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...

4/15/2025Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...

4/15/2025U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...

4/15/2025Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...

4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...

4/15/2025Gardasil9 Gains Expanded Approval in China

4/14/2025Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...

4/14/2025iRegene Advances Chemically-Induced iPSC Platform, Pioneers Cell Thera...

4/14/2025Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...

4/11/2025Recent Executive Moves

4/11/2025Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...

4/11/2025YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...

4/11/2025China Greenlights First Gene Therapy for Hemophilia B

Page:1/47 Total number of articles:1391: [First][<<] [1] [2] [3] [4] [5] [>>] [End]